🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where groups with numerous of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Content Removal

According to the social media company, the service has removed problematic content and prohibited associated hashtags and search suggestions. The company stated it was committed to maintaining the service safe and investing in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an guidebook and promised shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Pricing

Inside these communities, posts display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the research behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to possibly serious health risks”.